DOCSLIB.ORG

2017 Health for Humanity Report Progress in Citizenship & Sustainability 2017 Health for Humanity Report 2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2017 Health for Humanity Report Progress in Citizenship & Sustainability 2017 Health for Humanity Report 2 Executive Summary 2017 Health for Humanity Report Progress in Citizenship & Sustainability 2017 Health for Humanity Report 2 Message from Alex Gorsky It was created with the stroke of for you, our shareholders. It’s our way of a pen in 1886. demonstrating how we work to track and deliver on our commitments. James Wood Johnson, who co-founded the See, for example, how we’re eradicating and company with his brother Edward Mead preventing disease. Johnson, handcrafted one the world’s most trusted logos. James wanted the world to We’ve achieved great milestones as a know just how personally and emotionally company this year in our efforts to make connected the two were to the company’s HIV history with the initiation of the first most important reason for being—improving efficacy study for a preventative vaccine. I’m human health. So, he decided to use the encouraged every time I reflect on how far family signature. we’ve come since the 1980s with HIV, once considered a death sentence. All of us are Johnson & Johnson. humbled to be a part of the efforts to treat Placing their name on the company’s and protect—even, one day, prevent—HIV. products was the ultimate measure of I’m also proud of how we’re reimagining the accountability. It was a way of holding way that care is delivered and expanding themselves responsible for their—and their access for the world’s most vulnerable Alex and Pat Gorsky in Valmiki Basti, one of the oldest communities in New Delhi, India, where they visited the company’s—every action. In time, it became populations. homes of mMitra families. not just a trademark, but a mark that people learned they could trust. Because, after all, Our mMitra service immediately comes Helsingborg, Sweden became the first to changing the trajectory of health for trust and behavior go hand in hand. to mind. mMitra is an innovative mobile- Johnson & Johnson site receiving carbon- humanity. This sense of purpose has helped messaging program that sends vital health Serving generations of people with integrity, neutral status for all energy sources across us build on our company’s good name since information to expectant and new mothers caring and compassion remains our greatest manufacturing, R&D and warehouse the Johnson brothers, quite literally, put living in low-income urban communities in privilege and responsibility. Every day, facilities—a historic achievement that theirs on the company in 1886. India. The impact is irrefutable—mMitra has through our words and actions, we work improves human health while protecting the positively impacted the lives of one million I believe they’d be proud to put it on this tirelessly to earn our place in hearts, minds, environment and natural resources. women, and their children. This service has report, too. hospitals and households everywhere. had a transformative effect. And it earned Stories like these inspire and motivate us Much like the founding brothers—who were us a top spot on Fortune’s 2017 Change the every day. later joined by their brother, Robert Wood World list. Johnson—we continue to build on our While we’re pleased to share the progress reputation and the Johnson & Johnson name The report also shares our unwavering we’ve made in this report, we recognize through accountability and transparency. commitment to healthy minds, bodies and there’s more work to be done. And I’m Alex Gorsky environments. confident that we’ve got the best people And that’s exactly what our 2017 Health for in place to continue our sustainability Chairman, Board of Directors Humanity Report is all about. We’re making great progress toward our stewardship and commitment to being and Chief Executive Officer Health for Humanity 2020 Goals and It’s the story of our progress—our responsible global citizens—consistent with United Nations Sustainable Development the values outlined in Our Credo. environmental, social and governance WATCH VIDEO Goals focus areas. Our strong legacy of efforts—as we relentlessly drive for environmental stewardship, for example, The Health for Humanity Report is the better health and create long-term value continued in 2017 when our site in story of us. It showcases our commitment 2017 Health for Humanity Report 3 Sustainability Approach At Johnson & Johnson, we blend heart, expect us to lead. We believe that achieving science and ingenuity to profoundly change our goals is integral to Johnson & Johnson’s our 2017 Health for Humanity the trajectory of health for humanity. This long-term success and we consider them to Watch Report Year in Brief Highlights aspiration includes positively impacting be the Key Performance Indicators of our patients and all others who use our products, citizenship and sustainability approach. We as well as the health of our employees, our measure and track progress against the goals WATCH VIDEO communities and the planet. We seek to and report out on our progress annually, provide solutions for some of the world’s including independent review and assurance most pressing global public health challenges of our data. This data-driven approach allows and work collectively-within our walls- us to dedicate our resources efficiently and externally with partners to advance and effectively to the issues that are most better health for all. Our citizenship and impactful and important to all stakeholders. Review our Health for Humanity sustainability approach is inextricably linked In 2017, we continued making progress 2020 Goals Progress Scorecard to our vision of a world where a healthy mind, against our Health for Humanity 2020 Goals. body and environment is within reach for Please see Health for Humanity 2020 Goals everyone, everywhere. Progress Scorecard for more information. READ MORE We are driven by Our Credo, a set of values Our citizenship and sustainability and principles, that challenges and inspires approach also includes our commitment to us to put the needs and well-being of the support the global agenda on sustainable people we serve first. To us, these aren’t just development. We are working to help words: Our Credo serves as the foundation advance implementation of the United Learn more about our progress in of our mission as a healthcare company, and Nations Sustainable Development Goals (UN citizenship and sustainability is reflected in how we operate our business SDGs) across five key issue areas where we around the world. The long-term thinking of are uniquely positioned to create sustainable our founders, and current leadership, allow us and scalable impact. The summary of our VIEW 2017 REPORT to stay true to this vision. progress against UN SDG commitments can be found in our UN SDGs Scorecard, We’ve been setting five-year goals to improve reflecting cumulative progress from 2016 and the sustainability of our business for decades. 2017. For more information, please visit our In setting these goals, we strive to ensure that Sustainable Development Goals webpage. they are aligned with our company’s purpose, are embedded in our business strategy, and reflect the areas where our stakeholders 2017 Health for Humanity Report 4 2017 Year in Brief 51% 1.2 billion of supplier spend Recognized VERMOX (mebendazole) doses donated represented by suppliers as leaders in vaccine R&D by the since 2006* enrolled in Sustainable Access to Vaccines Index Procurement Program* JULUCA (dolutegravir and 45% of Manager and above 37,000 25% rilpivirine), developed patients in 95 countries provided of Company’s electricity talent movement was across in collaboration with ViiV access to MDR-TB therapy with use from renewable function, country or business Healthcare, the first and SIRTURO (bedaquiline)* energy sources* segment lines only complete, single- pill, two-drug regimen to treat HIV-1 infection approved by U.S. FDA Helsingborg, Sweden our 1st site achieving carbon (CO2)-neutral status for all energy sources across manufacturing, R&D and warehouse facilities** 8 weeks Global Parental Leave Standard launched— “A” Actelion employees globally can take in CDP Supplier Engagement joined our company, adding a minimum of 8 weeks' paid Rating, recognized for outstanding pulmonary hypertension as leave for birth/adoption performance in supplier engagement Janssen's 6th therapeutic area *Assured by third-party, ERM Certification and Verification Services Inc.; figures have been rounded. **Assured by third-party, ERM Certification and Verification Services Inc., for the period of 1 March 2017 to 31 December 2017. 2017 Health for Humanity Report 5 Better Health For All At Johnson & Johnson, health is our the governments of Norway and Germany we marked a milestone in 2017 in Africa for business. For more than 130 years, we have and other organizations to form a unique supporting the front lines of health. By the been committed to improving the health of We’re joining forces with the public–private partnership, the Coalition for end of the year, more than 10,500 healthcare individuals, families and communities around “world’s leading HIV researchers Epidemic Preparedness. providers had received critical skills training the world, including the most vulnerable and and global health advocates to from the Medical and Surgical Skills underserved populations, driving innovation help advance our experimental Strengthening Health Systems Institute, based in Ghana. This engagement and collaboration to change the trajectory of [HIV] vaccine. Working together, Strong, well-functioning health systems are in part of our U.N. Sustainable Development health for humanity. Our global public health our ultimate goal is to support imperative for advancing human health. Goals Essential Surgery commitment area. strategy is focused on tackling some of the efforts to make HIV history. Around the world, we are working with world’s most pressing health challenges, ” many stakeholders and leveraging our During the events in 2017 related to Paul Stoffels, Chief Scientific Officer, global expertise in health and on-the-ground Hurricanes Irma, Maria and Harvey and the including HIV, tuberculosis, neglected Johnson & Johnson tropical diseases, and the growing burden of presence in different regions to advocate Earthquake in Mexico, we provided both non-communicable diseases.
Load more

Recommended publications
  • Vers Un Modèle D'entreprise Hybride: L'évolution De La Gestion D'un Contexte De Loyauté Réciproque Vers Un Modèle De Marchés; Étude Du Cas De Johnson & Johnson
    UNIVERSITÉ DU QUÉBEC À MONTRÉAL VERS UN MODÈLE D'ENTREPRISE HYBRIDE: L'ÉVOLUTION DE LA GESTION D'UN CONTEXTE DE LOYAUTÉ RÉCIPROQUE VERS UN MODÈLE DE MARCHÉS; ÉTUDE DU CAS DE JOHNSON & JOHNSON MÉMOIRE PRÉSENTÉ COMME EXIGENCE PARTIELLE DELA MAÎTRISE EN ADMINISTRATION DES AFFAIRES (MBA-RECHERCHE) PAR FRÉDÉRIC TREMBLAY Novembre 2008 UNIVERSITÉ DU QUÉBEC À MONTRÉAL Service des bibliothèques Avertissement La diffusion de ce mémoire se fait dans le respect des droits de son auteur, qui a signé le formulaire Autorisation de reproduire et de diffuser un travail de recherche de cycles supérieurs (SDU-522 - Rév.01-2006). Cette autorisation stipule que «conformément à l'article 11 du Règlement no 8 des études de cycles supérieurs, [l'auteur] concède à l'Université du Québec à Montréal une licence non exclusive d'utilisation et de publication de la totalité ou d'une partie importante de [son] travail de recherche pour des fins pédagogiques et non commerciales. Plus précisément, [l'auteur] autorise l'Université du Québec à Montréal à reproduire, diffuser, prêter, distribuer ou vendre des copies de [son] travail de recherche à des fins non commerciales sur quelque support que ce soit, y compris l'Internet. Cette licence et cette autorisation n'entraînent pas une renonciation de [la] part [de l'auteur] à [ses] droits moraux ni à [ses] droits de propriété intellectuelle. Sauf entente contraire, [l'auteur] conserve la liberté de diffuser et de commercialiser ou non ce travail dont [il] possède un exemplaire.» REMERCIEMENTS La réalisation d'un mémoire de maîtrise est un travail exigeant, mais très formateur. Il pousse au dépassement de soi et à la réalisation de rêves autrefois formulés.
    [Show full text]
  • 137814.Pdf (857.3Kb)
    UNIVERSIDAD PANAMERICANA FACULTAD DE FILOSOFÍA Y CIENCIAS SOCIALES ESCUELA DE PEDAGOGÍA HR Redesing C A S O Q U E P R E S E N T A ALEXIS TANIA CORELLA RAMÍREZ P A R A O B T E N E R E L G R A D O D E : MAESTRA EN CAPITAL HUMANO DIRECTOR DE LA TESIS: Dr. DAVID RENE THIERRY GARCÍA MÉXICO, D.F. 17 DE DICIEMBRE DEL 2012 Universidad Panamericana 2 HR Redesing Índice Introducción ....................................................................................................................................................... 3 Marco Contextual ............................................................................................................................................... 4 Historia de Johnson & Johnson ................................................................................................................... 4 Medical Devices & Diagnostics .................................................................................................................... 5 Global Surgery Group ................................................................................................................................. 5 Global Medical Solutions ............................................................................................................................. 6 Global Orthopaedics Group ......................................................................................................................... 6 Filosofía Institucional – Nuestro Credo .....................................................................................................
    [Show full text]
  • I Project Number
    Project Number: DTZ 1103 An Interactive Qualifying Project Report: Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE in partial fulfillment of the requirements for the Degree of Bachelor of Science By Joshua Nitso _____________________________ Kevin Woods _____________________________ Submitted April 23, 2012 Approved by Professor Dalin Tang, Project Advisor _____________________________________________ I ABSTRACT The history of the stock market and selected companies within the pharmaceutical industry were studied using the Internet and Gordon Library as primary resources. An eight-week simulation was conducted on the stock market using different trading techniques that were analyzed and compared for effectiveness. Using these strategies helped develop a basic understanding of the investing world and the relative success of different investment methods. II TABLE OF CONTENTS ABSTRACT .................................................................................................................................... II TABLE OF CONTENTS .............................................................................................................. III TABLE OF FIGURES ....................................................................................................................V TABLE OF TABLES .................................................................................................................. VII 1. INTRODUCTION .....................................................................................................................
    [Show full text]
  • Johnson & Johnson
    Johnson & Johnson Johnson & Johnson is a U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson ranked at the top of Harris Interactive's National Corporate Reputation Survey for seven consecutive years up to 2005,[2] was ranked as the world's most respected company by Barron's Magazine in 2008,[3] and was the first corporation awarded the Benjamin Franklin Award for Public Diplomacy by the U.S. State Department in 2005 for its funding of international education programs. However, in recent years the company's reputation has been adversely affected by product recalls, fines for pharmaceutical marketing practices, litigation with a group of shareholders, and other legal issues. Johnson & Johnson is headquartered in New Brunswick, New Jersey with the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in over 57 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $65 billion for the calendar year of 2011.[4] Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses. On December 31, 2012, the Food and Drug Administration approved Sirturo, a Johnson & Johnson tuberculosis drug that is the first new medicine to fight the infection in more than forty years.
    [Show full text]
  • Standort Deutschland
    FIRMENPORTRÄT JOHNSON & JOHNSON GMBH Hier zu Lande hat Johnson & Johnson Consumer Health Care Germany etwa 730 Beschäftigte – davon allein rund 330 Mitarbeiter am Standort Neuss. Standort Deutschland Die Johnson & Johnson GmbH mit Sitz in Neuss ist eine deutsche Johnson stets an den Bedürfnissen Tochter des gleichnamigen Konzerns. Mit rund 114 000 Mitarbeitern der Menschen orientiert. Was 1886 mit Pflastern und Produkten zur in mehr als 250 Gesellschaften zählt das Unternehmen zu den sterilen Wundversorgung begann, weltweit größten in der Gesundheitsfürsorge. In diesem Jahr feiert wuchs im Laufe der Zeit zu einem Johnson & Johnson sein 125-jähriges Bestehen. vielseitigen Angebot der Gesund- heitsfürsorge. Eine Vision wird gelebt Im Jahr 1870 starb noch jedes dritte Neu - as internationale Unter- Arzneimittel des Johnson & Johnson geborene vor seinem ersten Ge- nehmen mit Hauptsitz Konzerns wurden von der Weltge- burtstag. Infektionskrankheiten auf- in New Brunswick im sundheitsorganisation bereits in das grund mangelnder Hygiene waren US-Bundesstaat New Verzeichnis der wichtigsten Medika- häufig die Ursache. Die drei Brüder DJersey ist in 57 Ländern der Welt ver- mente aufgenommen. Mit seinen Robert, James und Edward Johnson treten und hat mit seinen Innovatio- Produkten erreicht das Unternehmen hatten die Vision, die Hygienebe - nen die Therapie vieler Erkrankun- täglich mehr als eine Milliarde Per- dingungen in Krankenhäusern und gen entscheidend verbessert. Fünf sonen. Dabei hat sich Johnson & Arztpraxen zu verbessern und grün- 108 DIE PTA IN DER APOTHEKE | Oktober 2011 | www.pta-aktuell.de lichung von Johnson & Johnson, „Moderne Methoden der antisep - Firmengeschichte tischen Wundbehandlung“, wurde 1888 zum Standardwerk in der anti- im Überlick: septischen Chirurgie. Sie trug dazu 1886 – Unternehmensgründung in bei, die Anwendung steriler Behand- New Brunswick, New Jersey, USA.
    [Show full text]
  • Johnson & Johnson
    9/9/13 Johnson & Johnson - Wikipedia, the free encyclopedia Johnson & Johnson Coordinates: 40°29′55″N 74°26′37″W From Wikipedia, the free encyclopedia Johnson & Johnson is a U.S multinational Johnson & Johnson medical devices, pharmaceutical and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Type Public Average and the company is listed among the Fortune 500. Traded as NYSE: JNJ (http://www.nyse.com/about/listed/lcddata.html? Johnson & Johnson ranked at the top of ticker=jnj) Harris Interactive's National Corporate Dow Jones Industrial Average Component Reputation Survey for seven consecutive S&P 500 Component years up to 2005,[2] was ranked as the world's most respected company by Industry Medical equipment Barron's Magazine in 2008,[3] and was the Pharmaceutical first corporation awarded the Benjamin Founded 1886 Franklin Award for Public Diplomacy by Founder(s) Robert Wood Johnson I, the U.S. State Department in 2005 for its James Wood Johnson, funding of international education programs. Edward Mead Johnson However, in recent years the company's reputation has been adversely affected by Headquarters New Brunswick, New Jersey, United States product recalls, fines for pharmaceutical Area served Worldwide marketing practices, litigation with a group of shareholders, and other legal issues. Key people William Weldon (Chairman of the Board) Johnson & Johnson is headquartered in Alex Gorsky New Brunswick, New Jersey with the (Chief Executive Officer) consumer division being located in Products See list of Johnson & Johnson products Skillman, New Jersey. The corporation includes some 250 subsidiary companies Revenue US$ 65.030 billion (2012)[1] with operations in over 57 countries and Operating US$ 12.361 billion (2012)[1] products sold in over 175 countries.
    [Show full text]
  • Plan Estratégico Johnson & Johnson 2011-2013
    “PLAN ESTRATÉGICO JOHNSON & JOHNSON 2011-2013” Trabajo de Investigación presentado para optar al Grado Académico de Magíster en Administración Presentado por Sr. Carlos Fernando Mendoza Canta Sr. Luis Miguel Maldonado Ortega Sr. José Luis Orejas Vega Asesora: Profesora Gina Pipoli de Azambuja 2017 Dedicamos el presente trabajo a nuestras familias, padres, hijos y amigos que nos apoyaron incondicionalmente en esta travesía. Además, a todos nuestros profesores y en especial a nuestra asesora de tesis Gina Pipoli por su orientación, asesoramiento, dedicación y por seguir apostando a través de la educación por el desarrollo de los peruanos. Resumen ejecutivo Johnson & Johnson (J&J), empresa con una larga trayectoria y sólida posición en el mercado a nivel global en el cuidado de la salud, a pesar de su liderazgo en la venta de productos farmacéuticos sin receta OTC en USA, estaba siendo cuestionada por la calidad de algunos de sus medicamentos emblemáticos en el periodo 2009-2010. Dada esta situación, se ha elaborado el presente plan estratégico para la categoría de medicamentos OTC, división consumo mercado USA, que le permita a J&J poder corregir los problemas que le ocasionaron una pérdida en sus ventas y participación de mercado. Para ello se inició con un análisis del entorno externo a través de la metodología PESTEL obteniendo una puntuación de 3,25 en la Matriz EFE, lo cual evidencia que las oportunidades superan a las amenazas por la recuperación de la situación económica del país, que principalmente ocurre en el último trimestre del 2010. Se continuó con la evaluación de la industria determinando su grado de atractividad, obteniendo un valor de 3,15, empleando como herramienta las cinco fuerzas de Porter.
    [Show full text]
  • Krisenresistente US-Investments
    INVESTMENT & STRATEGIE Krisenresistente US-Investments DIVIDENDENTITEL Die meisten der sogenannten Dividendenaristokraten haben trotz Pandemie an ihrer vorbildlichen Ausschüttungspolitik festgehalten. Möglich gemacht haben dies ihre guten Positionierungen in den angestammten Märkten, die sogar teilweise ausgebaut werden konnten. u den Titeln mit starker Positionierung gehört die Aktie man das 136. Quartal in ununterbrochener Folge eine Dividende des US-Baumarktriesen Home Depot. Home Depot ausgeschüttet. Der Konzern aus Cobb County im US-Bundesstaat wurde 1978 in Atlanta gegründet und betreibt mit rund Georgia zahlt auf das Jahr gerechnet 6,60 US-Dollar Dividende je 500.000 Mitarbeitern 2.296 Baumärkte in Nordamerika, China, Anteilsschein aus. Die Dividendenrendite beträgt aktuell 2,10 %. Mexiko, Guam, den Virgin Islands und Puerto Rico. Die nach eigenen Angaben weltgrößte Baumarktkette pro!tiert vom anhal- Dividendenzahler seit 60 Jahren tenden Bauboom und dem Trend zu mehr Heimwerkeraktivitäten Wettbewerber Lowe’s ist nach Home Depot die zweitgrößte in Zeiten des Lockdowns. Baumarktkette der Welt. Genau wie Home Depot pro!tierte auch Lowe’s vom Trend in den eigenen vier Wänden zu Do It Yourself Rekorderlös eingefahren (DIY). Als viele Läden geschlossen und Urlaubsziele unerreichbar Home Depot verzeichnete im Ende Januar beendeten Geschäfts- waren, wuchs der Wunsch der Menschen, das Eigenheim durch Bas- jahr 2020/21 einen Umsatzanstieg um 19,9 % auf 132,1 Mrd. teln, Gartenarbeit oder kleinere Heimwerkerarbeiten aufzuwerten. US-Dollar. Allein im vierten Quartal betrug der Umsatzzuwachs rund 25 %. Der Gewinn stieg im abgelaufenen Geschäftsjahr um Lowe’s Companies ist 1946 gegründet worden und hat seinen knapp 15 % auf 12,9 Mrd. US-Dollar. Firmensitz in Mooresville im US-Bundesstaat North Carolina.
    [Show full text]
  • [Propuesta De Mejora Del Proceso En Un Centro De Producción De Hilo
    [Propuesta de Mejora del Proceso en un Centro de Producción de Hilo Dental] MEMORIA PRESENTADA POR: [Johanny C. Ovalles Acosta] [Máster Universitario en Ingeniería de Organización y Logística] Convocatoria de defensa: [septiembre 2018] . Resumen Este reporte de investigación a desarrollar tiene como objetivo, analizar las principales razones por las que se generan eventos de No Calidad o No Conformes (NC) en un centro de producción de la planta de manufactura Johnson & Johnson Dental Care, R.D., dicho centro se encarga de producir subensambles que forman parte del hilo dental, siendo este el producto terminado o final que se manufactura en dicha planta. A fin de poder implementar acciones correctivas y preventivas para la eliminación o disminución de los eventos de No Calidad o No Conformes, se identificaron las principales herramientas de análisis de Causa Raíz, seleccionando el Diagrama de Ishikawa o también llamado Espina de Pescado para analizar profundamente la/s causa/s potenciales que generan la situación que se presenta en dicho centro. Del mismo modo la identificación de los mayores detractores que afectan el centro de producción, luego la verificación de los procedimientos e instrucciones de trabajo vigentes de dicho centro, a fin de retarlos contra la ejecución actual del proceso, igualmente identificar los cambios necesarios a implementar con el propósito de lograr una mejor manufactura y manejo de los subensambles y por consiguiente determinar los controles de calidad y las acciones recomendables a implementar para poder optimizar el proceso de manufactura de los subensambles. Summary: The objective of this investigation report to be developed is to analyze the main reasons of the generation of Non Quality or Non Conformances (NC) in a production center of Johnson & Johnson Dental Care, R.D.
    [Show full text]
  • 2017 Health for Humanity Report Progress in Citizenship & Sustainability Our JLABS @ TMC in Houston Boasts the Largest JLABS Footprint in the U.S
    2017 Health for Humanity Report Progress in Citizenship & Sustainability Our JLABS @ TMC in Houston boasts the largest JLABS footprint in the U.S.. Contents About Johnson & Johnson 3 Better Health for All 26 Responsible Business Practices 101 Johnson & Johnson At a Glance 3 World Without Disease 28 Product Quality, Safety & Reliability 102 Our Brands 3 Access to Healthcare 37 Ethics & Transparency 109 Strengthening Health Systems 42 Human Rights 117 Message from Alex Gorsky 5 Community Engagement 46 Information Security & Privacy 119 Responsible Supply Base 121 2017 Year In Brief 7 Innovation 50 Innovating How We Serve 51 Appendix 128 Sustainability Approach 8 Innovating How We Work 55 About This Report 128 Sustainability Governance 9 Independent Assurance Statements 130 Setting Priorities 11 Our People 57 Priority Topics Assessment 136 Our Value Chain 12 Commitment to Employees 60 GRI Index 139 Stakeholder Engagement 13 Diversity & Inclusion 68 UNGC Index 160 Employee Health & Wellness 73 Data Summary 164 Progress on Commitments 16 Employee Safety 75 Health for Humanity 2020 Goals 16 References 179 UN SDG Commitments 22 Environmental Health 79 EHS&S Governance 81 Optimizing Our Operations 83 Product Sustainability 95 2017 Health for Humanity Report 3 About Johnson & Johnson About Message from Alex Gorsky Johnson & Johnson At a Glance Johnson & Johnson is the largest and most diversified healthcare company in the world. We are 134,000 ~260 Year In Brief employees in 60 countries, united by a common purpose: to change the trajectory of health for humanity. We operating companies have been caring for people for over 130 years. This heritage of delivering trusted products and services drives Sustainability our three business segments: Consumer, Medical Devices and Pharmaceutical.
    [Show full text]
  • Pharmaceuticals Company
    Graduation Project Johnson&johnson DR/ Mohamed Elkaloubi Presented by Dalia Hani Mohamed Ramzy Abdelrahman soliman Sherif Mostafa Mahmoud The company Introduction: Caring for the world, one person at a time... inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. Our Family of Companies comprises: The world’s sixth-largest consumer health company The world’s largest and most diverse medical devices and diagnostics company The world’s sixth-largest biologics company And the world’s sixth-largest pharmaceuticals company We have more than 275 operating companies in more than 60 countries employing approximately 128,700 people. Our worldwide headquarters is in New Brunswick, New Jersey, USA. Business highlight 2013 Johnson & Johnson delivered strong results in 2013 led by the outstanding performance in our Pharmaceutical business, the re-launch and strength of key brands in our U.S. over-the- counter (OTC) and other Consumer businesses and continued progress in integrating Synthes, Inc. into our Medical Devices and Diagnostics (MD&D) segment. Results also included advances in our longer-term growth drivers including bringing innovative solutions to the global health care market, executing with excellence, and leading with purpose to advance health and well-being for patients and consumers around the world. PHARMACEUTICAL With $28.1 billion in worldwide sales in 2013, we are the seventh-largest pharmaceuticals business* in the world and the sixth-largest biotech business*.
    [Show full text]
  • 2010 ANNUAL REPORT Global Developer and Manufacturer of Minimally Invasive Devices for Hemorrhagic and Ischemic Stroke
    ANNUAL REPORT 2010 Despite an extraordinarily challenging year, our people introduced new products, advanced our pipelines and expanded businesses in emerging markets. We are on our way to restoring McNeil Consumer Healthcare to the high levels of quality and compliance that people expect of all Johnson & Johnson companies and that we expect of ourselves. Meanwhile, we are bringing forward innovations that better health care for people around the world. We remain steeped in our tradition of caring for others, driven by values deeply rooted in Our Credo. ON THE COVER Megan Johnson enjoys the simple everyday joys of motherhood. She receives important health care information through text4baby, an innovative mobile service for expectant and new mothers made possible by the National Healthy Mothers, Healthy Babies Coalition, founding sponsor Johnson & Johnson and multiple other partners. Text4baby symbolizes our commitment to caring for the health and well-being of mothers and babies, the Johnson & Johnson legacy for 125 years. Learn more on page 24. CHAIRMAN’S LETTER To Our Shareholders 2010 will be remembered as a year in which our company was WilliaM c. WeldoN severely tested on numerous fronts. Yet our people continued Chairman, Board of Directors, and Chief Executive Officer the hallmark work of Johnson & Johnson: finding new ways to care for the health and well-being of people around the world. while maintaining investments for future revenue and earnings There were challenges we fully expected, particularly those growth. With these investments, we are developing a number related to the continuing global economic downturn and loss of of exciting new products that have the potential to address patent exclusivity on some of our major pharmaceutical products.
    [Show full text]